Newcastle-upon-Tyne Hospitals NHS Trust
newcastle-hospitals.nhs.ukTotal trials
67
Active
6
Phase 3
4
Total enrollment
113,360
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Risdiplam | — | — | — | — | — | 1 | |
| Nusinersen Injectable Product | — | — | — | — | — | 1 |
Next readouts
- 2027-04-30
Top conditions
- Rheumatoid Arthritis3
- Type 2 Diabetes Mellitus2
- Acute Coronary Syndrome2
- Mitochondrial Diseases2
- Healthy2
- Parkinson's Disease2
- Diastolic Dysfunction1
- Spinal Muscular Atrophy (SMA)1
Frequently asked questions about Newcastle-upon-Tyne Hospitals NHS Trust
- How many clinical trials does Newcastle-upon-Tyne Hospitals NHS Trust have on ClinicalTrials.gov?
- Newcastle-upon-Tyne Hospitals NHS Trust is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Newcastle-upon-Tyne Hospitals NHS Trust's trials are in Phase 3?
- 4 of Newcastle-upon-Tyne Hospitals NHS Trust's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Newcastle-upon-Tyne Hospitals NHS Trust focus on?
- Newcastle-upon-Tyne Hospitals NHS Trust's most-studied conditions on ClinicalTrials.gov are Rheumatoid Arthritis, Type 2 Diabetes Mellitus, Acute Coronary Syndrome, Mitochondrial Diseases, Healthy.
- When are Newcastle-upon-Tyne Hospitals NHS Trust's next clinical trial readouts?
- Newcastle-upon-Tyne Hospitals NHS Trust has 1 upcoming primary-completion readout tracked here; the soonest is “Adult SMA Research and Clinical Hub”, expected around 2027-04-30.